Published on 24/10/2025 by Shen Awards 55 / 100 Powered by Rank Math SEO SEO Score Dr. Viola Pomozi | Diabetes | Best Researcher Award HUN-REN RCNS, Hungary Dr. Viola Pomozi is a distinguished molecular biologist whose research has significantly advanced the understanding of ectopic calcification, diabetes-related tissue mineralization, and pyrophosphate metabolism. Her pioneering work has focused on elucidating the molecular mechanisms underlying soft tissue calcification, particularly the role of the ABCC6 transporter and its relationship with metabolic disorders such as diabetes and atherosclerosis. Dr. Pomozi has been instrumental in developing innovative in vitro and in vivo models to explore the regulation, localization, and function of ABCC6, leading to novel insights into its role in preventing pathological calcification. A major highlight of her research is the groundbreaking discovery that orally administered pyrophosphate can be absorbed in both mice and humans—a finding that challenges long-held scientific assumptions. This discovery has paved the way for two ongoing clinical trials investigating the therapeutic use of oral pyrophosphate supplementation in patients with genetic calcification disorders, showcasing the strong translational and clinical relevance of her research. Dr. Pomozi has authored 27 publications indexed in Scopus, with a citation count exceeding 782 and an H-index of 16, reflecting the global impact and recognition of her scientific contributions. Her collaborative projects span internationally across renowned institutions, including Queen’s University Belfast, the University of Hawaii, and the University of Debrecen, emphasizing the interdisciplinary and global nature of her research. In addition to her experimental expertise, she has demonstrated strong analytical and methodological skills in molecular biology, animal modeling, and biochemical analysis. Her ongoing studies on diabetes-induced soft tissue calcification continue to deepen the understanding of metabolic regulation and therapeutic intervention. Through her commitment to high-impact, translational research, Dr. Viola Pomozi’s work stands at the intersection of basic science and clinical innovation, contributing profoundly to medical science and offering tangible hope for patients suffering from calcification-related diseases worldwide. Profiles: Scopus | ORCID Featured Publications Pomozi, V., Terry, S. F., & Váradi, A. (2024, November). The 2023 PXE calcification meeting in Budapest: A focus on clinical trials for this disease. Journal of Investigative Dermatology. Brampton, C., Pomozi, V., Le Corre, Y., Zoll, J., Kauffenstein, G., Ma, C., Hoffmann, P. R., Martin, L., & Le Saux, O. (2024, August). Bone marrow–derived ABCC6 is an essential regulator of ectopic calcification in pseudoxanthoma elasticum. Journal of Investigative Dermatology. Dr. Viola Pomozi’s research bridges molecular biology and clinical medicine, transforming the understanding of soft tissue calcification and metabolic disorders. Her groundbreaking discovery on oral pyrophosphate absorption offers a novel therapeutic avenue with global potential to prevent calcification-related diseases, advancing both scientific innovation and public health outcomes. Viola Pomozi | Diabetes | Best Researcher Award
Dr. Viola Pomozi is a distinguished molecular biologist whose research has significantly advanced the understanding of ectopic calcification, diabetes-related tissue mineralization, and pyrophosphate metabolism. Her pioneering work has focused on elucidating the molecular mechanisms underlying soft tissue calcification, particularly the role of the ABCC6 transporter and its relationship with metabolic disorders such as diabetes and atherosclerosis. Dr. Pomozi has been instrumental in developing innovative in vitro and in vivo models to explore the regulation, localization, and function of ABCC6, leading to novel insights into its role in preventing pathological calcification. A major highlight of her research is the groundbreaking discovery that orally administered pyrophosphate can be absorbed in both mice and humans—a finding that challenges long-held scientific assumptions. This discovery has paved the way for two ongoing clinical trials investigating the therapeutic use of oral pyrophosphate supplementation in patients with genetic calcification disorders, showcasing the strong translational and clinical relevance of her research. Dr. Pomozi has authored 27 publications indexed in Scopus, with a citation count exceeding 782 and an H-index of 16, reflecting the global impact and recognition of her scientific contributions. Her collaborative projects span internationally across renowned institutions, including Queen’s University Belfast, the University of Hawaii, and the University of Debrecen, emphasizing the interdisciplinary and global nature of her research. In addition to her experimental expertise, she has demonstrated strong analytical and methodological skills in molecular biology, animal modeling, and biochemical analysis. Her ongoing studies on diabetes-induced soft tissue calcification continue to deepen the understanding of metabolic regulation and therapeutic intervention. Through her commitment to high-impact, translational research, Dr. Viola Pomozi’s work stands at the intersection of basic science and clinical innovation, contributing profoundly to medical science and offering tangible hope for patients suffering from calcification-related diseases worldwide. Profiles: Scopus | ORCID Featured Publications Pomozi, V., Terry, S. F., & Váradi, A. (2024, November). The 2023 PXE calcification meeting in Budapest: A focus on clinical trials for this disease. Journal of Investigative Dermatology. Brampton, C., Pomozi, V., Le Corre, Y., Zoll, J., Kauffenstein, G., Ma, C., Hoffmann, P. R., Martin, L., & Le Saux, O. (2024, August). Bone marrow–derived ABCC6 is an essential regulator of ectopic calcification in pseudoxanthoma elasticum. Journal of Investigative Dermatology. Dr. Viola Pomozi’s research bridges molecular biology and clinical medicine, transforming the understanding of soft tissue calcification and metabolic disorders. Her groundbreaking discovery on oral pyrophosphate absorption offers a novel therapeutic avenue with global potential to prevent calcification-related diseases, advancing both scientific innovation and public health outcomes.
Dr. Viola Pomozi is a distinguished molecular biologist whose research has significantly advanced the understanding of ectopic calcification, diabetes-related tissue mineralization, and pyrophosphate metabolism. Her pioneering work has focused on elucidating the molecular mechanisms underlying soft tissue calcification, particularly the role of the ABCC6 transporter and its relationship with metabolic disorders such as diabetes and atherosclerosis. Dr. Pomozi has been instrumental in developing innovative in vitro and in vivo models to explore the regulation, localization, and function of ABCC6, leading to novel insights into its role in preventing pathological calcification. A major highlight of her research is the groundbreaking discovery that orally administered pyrophosphate can be absorbed in both mice and humans—a finding that challenges long-held scientific assumptions. This discovery has paved the way for two ongoing clinical trials investigating the therapeutic use of oral pyrophosphate supplementation in patients with genetic calcification disorders, showcasing the strong translational and clinical relevance of her research. Dr. Pomozi has authored 27 publications indexed in Scopus, with a citation count exceeding 782 and an H-index of 16, reflecting the global impact and recognition of her scientific contributions. Her collaborative projects span internationally across renowned institutions, including Queen’s University Belfast, the University of Hawaii, and the University of Debrecen, emphasizing the interdisciplinary and global nature of her research. In addition to her experimental expertise, she has demonstrated strong analytical and methodological skills in molecular biology, animal modeling, and biochemical analysis. Her ongoing studies on diabetes-induced soft tissue calcification continue to deepen the understanding of metabolic regulation and therapeutic intervention. Through her commitment to high-impact, translational research, Dr. Viola Pomozi’s work stands at the intersection of basic science and clinical innovation, contributing profoundly to medical science and offering tangible hope for patients suffering from calcification-related diseases worldwide. Profiles: Scopus | ORCID Featured Publications Pomozi, V., Terry, S. F., & Váradi, A. (2024, November). The 2023 PXE calcification meeting in Budapest: A focus on clinical trials for this disease. Journal of Investigative Dermatology. Brampton, C., Pomozi, V., Le Corre, Y., Zoll, J., Kauffenstein, G., Ma, C., Hoffmann, P. R., Martin, L., & Le Saux, O. (2024, August). Bone marrow–derived ABCC6 is an essential regulator of ectopic calcification in pseudoxanthoma elasticum. Journal of Investigative Dermatology. Dr. Viola Pomozi’s research bridges molecular biology and clinical medicine, transforming the understanding of soft tissue calcification and metabolic disorders. Her groundbreaking discovery on oral pyrophosphate absorption offers a novel therapeutic avenue with global potential to prevent calcification-related diseases, advancing both scientific innovation and public health outcomes.